• Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
  

PubMed=3029758; DOI=10.1073/pnas.84.4.1005
Sells M.A., Chen M.L., Acs G.
Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.
Proc. Natl. Acad. Sci. U.S.A. 84:1005-1009(1987)

PubMed=8224613; DOI=10.1096/fasebj.7.14.8224613
Puisieux A., Galvin K., Troalen F., Bressac B., Marcais C., Galun E., Ponchel F., Yakicier C., Ji J.-W., Ozturk M.
Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines.
FASEB J. 7:1407-1413(1993)

PubMed=21448419; DOI=10.3748/wjg.v17.i9.1152
Zhao R., Wang T.-Z., Kong D., Zhang L., Meng H.-X., Jiang Y., Wu Y.-Q., Yu Z.-X., Jin X.-M.
Hepatoma cell line HepG2.2.15 demonstrates distinct biological features compared with parental HepG2.
World J. Gastroenterol. 17:1152-1159(2011)

PubMed=29481805; DOI=10.1016/j.bbrc.2018.02.175
Ogura N., Ogawa K., Watashi K., Ito T., Wakita T.
Novel stable HBV producing cell line systems for expression and screening antiviral inhibitor of hepatitis B virus in human hepatoma cell line.
Biochem. Biophys. Res. Commun. 498:64-71(2018)